Beam Therapeutics

Our vision is to provide life-long cures for patients suffering from serious diseases.

Biotechnology Research · Massachusetts

About

The foundational level of our genetic information is a single base in our DNA. A change to a single letter, known as a point mutation, can mean the difference between health and disease. Base editors have the ability to rewrite just a single letter, and thereby intervene at the most foundational level to treat a wide range of diseases. We are “The Beam Team.” Breakthroughs in genetic medicines require a unique combination of cutting-edge exploratory science to enable new possibilities, and industrial rigor to convert them into therapeutic reality. Our values define how we work together: A community of fearless innovators Rigorous and honest in our research Listening with open minds Committed to each other

Details

  • Website: http://beamtx.com
  • Founded: 2017
  • Company Size: 597 employees
  • Headquarters: Cambridge, Massachusetts
  • Specialties: gene therapy, base editing, gene editing, precision medicines, CRISPR, CRISPR Cas9, genetic diseases, rare diseases, hematology, lipid nanoparticles, LNP, vector production, AAV, In vivo, ex vivo, Liver, mRNA Production, mRNA, DNA, RNA, Cas9, drug development, drug delivery, immunology, formulation development, virology, viral delivery, nanoparticles formulation, structural biology, cell biology, protein sciences, cell therapy